ORKA Chart
See on advanced chart >
About
Oruka Therapeutics, Inc. is a biopharmaceutical company whose principal focus is developing genetically-targeted therapies for cardiovascular diseases. The company's lead product candidate, Gencaro TM(bucindolol hydrochloride), a pharmacologically unique...
Read More
- HighlightA biotechnology company focused on developing innovative drugs for the treatment of chronic skin diseases
- ExchangeNASDAQ
- Listing Date08/08/1997
- Established DateInvalid Date
- Full-time Employees4
- Address10170 Church Ranch Way Suite 100 Westminster Colorado 80021
- Tel1-720-9402100
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Biotechnology